India’s biotech growth needs more long-term capital, says expert
An industry specialist says India's biotechnology sector, which has been expanding, requires additional long‑term financing to sustain its growth. Current funding sources are viewed as insufficient, and investors with patient capital are needed to support research, product development and scaling. The call highlights a funding gap that could hinder the sector's future progress in India.